Your browser doesn't support javascript.
loading
A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort.
Christakoudi, Sofia; Tsilidis, Konstantinos K; Dossus, Laure; Rinaldi, Sabina; Weiderpass, Elisabete; Antoniussen, Christian S; Dahm, Christina C; Tjønneland, Anne; Mellemkjær, Lene; Katzke, Verena; Kaaks, Rudolf; Schulze, Matthias B; Masala, Giovanna; Grioni, Sara; Panico, Salvatore; Tumino, Rosario; Sacerdote, Carlotta; May, Anne M; Monninkhof, Evelyn M; Quirós, J Ramón; Bonet, Catalina; Sánchez, Maria-Jose; Amiano, Pilar; Chirlaque, María-Dolores; Guevara, Marcela; Rosendahl, Ann H; Stocks, Tanja; Perez-Cornago, Aurora; Tin Tin, Sandar; Heath, Alicia K; Aglago, Elom K; Peruchet-Noray, Laia; Freisling, Heinz; Riboli, Elio.
Afiliación
  • Christakoudi S; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, UK. s.christakoudi@imperial.ac.uk.
  • Tsilidis KK; Department of Inflammation Biology, School of Immunology & Microbial Sciences, King's College London, London, UK. s.christakoudi@imperial.ac.uk.
  • Dossus L; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, St Mary's Campus, Norfolk Place, London, W2 1PG, UK.
  • Rinaldi S; Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, Greece.
  • Weiderpass E; International Agency for Research on Cancer (IARC/WHO), 25 avenue Tony Garnier, Lyon, CS 90627, 69366 LYON CEDEX 07, France.
  • Antoniussen CS; International Agency for Research on Cancer (IARC/WHO), 25 avenue Tony Garnier, Lyon, CS 90627, 69366 LYON CEDEX 07, France.
  • Dahm CC; International Agency for Research on Cancer (IARC/WHO), 25 avenue Tony Garnier, Lyon, CS 90627, 69366 LYON CEDEX 07, France.
  • Tjønneland A; Department of Public Health, Aarhus University, Bartholins Allé 2, Aarhus C, DK-8000, Denmark.
  • Mellemkjær L; Department of Public Health, Aarhus University, Bartholins Allé 2, Aarhus C, DK-8000, Denmark.
  • Katzke V; Diet, Cancer and Health, Danish Cancer Society Research Center, Strandboulevarden 49, Copenhagen, DK-2100, Denmark.
  • Kaaks R; Department of Public Health, University of Copenhagen, Copenhagen, Denmark.
  • Schulze MB; Diet, Cancer and Health, Danish Cancer Society Research Center, Strandboulevarden 49, Copenhagen, DK-2100, Denmark.
  • Masala G; Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Grioni S; Department of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Panico S; Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, 14558, Germany.
  • Tumino R; Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.
  • Sacerdote C; Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy.
  • May AM; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Via Venezian 1, Milano, 20133, Italy.
  • Monninkhof EM; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Quirós JR; Hyblean Association Epidemiological Research AIRE - ONLUS, Ragusa, Italy.
  • Bonet C; Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital, Via Santena 7, Turin, 10126, Italy.
  • Sánchez MJ; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, Utrecht, 3508 GA, Netherlands.
  • Amiano P; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, P.O. Box 85500, Utrecht, 3508 GA, Netherlands.
  • Chirlaque MD; Public Health Directorate, Asturias, Spain.
  • Guevara M; Unit of Nutrition and Cancer, Catalan Institute of Oncology - ICO, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Rosendahl AH; Nutrition and Cancer Group; Epidemiology, Public Health, Cancer Prevention and Palliative Care Program, Bellvitge Biomedical Research Institute - IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Stocks T; Escuela Andaluza de Salud Pública (EASP), Granada, 18011, Spain.
  • Perez-Cornago A; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, 18012, Spain.
  • Tin Tin S; Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, 28029, Spain.
  • Heath AK; Department of Preventive Medicine and Public Health, University of Granada, Granada, 18071, Spain.
  • Aglago EK; Ministry of Health of the Basque Government, Sub Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain.
  • Peruchet-Noray L; Epidemiology of Chronic and Communicable Diseases Group, Biodonostia Health Research Institute, San Sebastián, Spain.
  • Freisling H; Spanish Consortium for Research on Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain.
  • Riboli E; Department of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia University, Murcia, Spain.
BMC Cancer ; 23(1): 562, 2023 Jun 19.
Article en En | MEDLINE | ID: mdl-37337133

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Neoplasias de la Mama Triple Negativas Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido